<DOC>
	<DOCNO>NCT00658788</DOCNO>
	<brief_summary>The primary objective study evaluate safety &amp; efficacy consecutive treatment Clobex® Spray Silkis® Ointment management plaque psoriasis .</brief_summary>
	<brief_title>Safety &amp; Effectiveness Clobex Spray , Followed Calcitriol Ointment Management Plaque Psoriasis</brief_title>
	<detailed_description>Same .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Diagnosis moderate severe plaque psoriasis , define 3 % 20 % treatable body surface area Overall Disease Severity least 3 ( moderate ) Surface area involvement large ( &gt; 20 % BSA ) Psoriasis involve scalp , groin , axilla , and/or intertriginous area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>